VAN HEUVELEN STRATEGIES, LLC for ALLERGAN PLC (FORMERLY KNOWN AS ACTAVIS)
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
Issues related to the CMS Part B Drugs Payment Model Demo
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT VAN HEUVELEN | Chief of Staff to Senator Kent Conrad |
| STEPHEN DOUGLAS WARD | Chief of Staff to Senator Jeff Bingaman |
Taxation/Internal Revenue Code TAX
Issues related to the CMS Part B Drugs Payment Model Demo
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT VAN HEUVELEN | Chief of Staff to Senator Kent Conrad |
| STEPHEN DOUGLAS WARD | Chief of Staff to Senator Jeff Bingaman |
Copyright/Patent/Trademark CPT
Issues related to the CMS Part B Drugs Payment Model Demo
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT VAN HEUVELEN | Chief of Staff to Senator Kent Conrad |
| STEPHEN DOUGLAS WARD | Chief of Staff to Senator Jeff Bingaman |
Health Issues HCR
Issues related to the CMS Part B Drugs Payment Model Demo Issues related to Zika funding H.R. 5325 - Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act H.R. 6 - 21st Century Cures Act S. 2615 - Increasing Competition in Pharmaceuticals Act H.R. 4784 -Lower Drug Costs through Competition Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT VAN HEUVELEN | Chief of Staff to Senator Kent Conrad |
| STEPHEN DOUGLAS WARD | Chief of Staff to Senator Jeff Bingaman |
Budget/Appropriations BUD
Issues related to the CMS Part B Drugs Payment Model Demo
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT VAN HEUVELEN | Chief of Staff to Senator Kent Conrad |
| STEPHEN DOUGLAS WARD | Chief of Staff to Senator Jeff Bingaman |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.